Atlas Trials

Ursodeoxycholic Acid (UDCA) for Hepatic Sarcoidosis

Clinical trial NCT03602976 · TERMINATED

Trial details

NCT number
NCT03602976
Sponsor
Ethan Weinberg
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatic Sarcoidosis, Elevated Alkaline Phosphatase
Start date
2018-08-20
Primary completion
2022-01-12
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.